Skip to main content
SpringerLink
Log in

Continuous Pharmaceutical Crystallization from Solution

  • Chapter
  • First Online:
Engineering Crystallography: From Molecule to Crystal to Functional Form

Abstract

The pharmaceutical industry has traditionally employed exclusively batch manufacturing for drug substances. The current trend is to explore continuous manufacturing; this chapter describes the process by which a continuous pharmaceutical crystallization process can be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Agricola G (1556) De Re Metallica. Froben, Basel

    Google Scholar 

  2. Kestner P (1911) Process of crystallizing sugar US patent 989366 11 April 1911

    Google Scholar 

  3. Randolph A, Larson M (1998) Theory of particulate processes analysis and techniques of continuous crystallization, 2nd edn. Academic, San Diego

    Google Scholar 

  4. Mersmann A, Rennie FW (2001) Operation of crystallizers. In: Mersmann A (ed) Crystallization technology handbook. CRC Press, Hoboken

    Chapter  Google Scholar 

  5. Patel DD, Anderson BD (2013) Maintenance of supersaturation II: Indomethacin crystal growth kinetics versus degree of supersaturation. J Pharm Sci 102(5):1544–1553

    Article  CAS  Google Scholar 

  6. Vendel M, Rasmuson Å (1997) Mechanisms of initiation of incrustation. Am Inst Chem Eng J 43(5):1300–1308

    Article  CAS  Google Scholar 

  7. Majumder A, Nagy ZK (2015) Dynamic modeling of encrust formation and mitigation strategy in a continuous plug flow crystallizer. Crystal Growth Des 15(3):1129–1140

    Article  CAS  Google Scholar 

  8. Whiting Equipment Canada Inc. (2015) Swenson crystallization equipment. Available on line: http://crystallisation.pbworks.com/f/Swenson+Crystallization+Equipment.pdf. Accessed 17 Oct 2015

  9. Samant KD, O'Young L (2006) Understanding crystallization and crystallizers. Chem Eng Prog 102:28–37

    CAS  Google Scholar 

  10. Baxendale IR, Braatz RD, Hodnett BK, Jensen KF, Johnson MD, Sharratt P, Sherlock J-P, Florence AJ (2014) Achieving continuous manufacturing: technologies and approaches for synthesis, work-up and isolation of drug substance. Presented at The International Symposium on Continuous Manufacturing of Pharmaceuticals MIT 20th 21st May 2014

    Google Scholar 

  11. US Food and Drug Administration (2009) Guidance for industry residual solvents in drug products marketed in the United States Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER)

    Google Scholar 

  12. Igarashi K, Yamanaka Y, Azuma M, Ooshima H (2012) Control of crystal size distribution using a mL-scale continuous crystallizer equipped with a high speed agitator. J Chem Eng Jpn 45(1):28–33

    Article  CAS  Google Scholar 

  13. Cross WI, Hannan ML, Johns DM, Lee M-Y, Price CJ (2006) Novel crystalline pharmaceutical product. US 2009/0124585 A1 6 Apr 2006

    Google Scholar 

  14. Price CJ (2012) Developing pharmaceutical continuous crystallization processes – knowledge & gaps. Presented at the National Centre for Continuous Manufacturing and Crystallization Annual Conference September 2012. Available on line: http://www.cmac.ac.uk/files/media/Chris_Price_-_GSK.pdf. Accessed 22 Oct 2015

  15. Lawton S, Steele G, Shering P, Zhao L, Laird I, Ni X (2009) Continuous crystallization of pharmaceuticals using a continuous oscillatory baffled crystallizer. Org Process Res Dev 13(6):1357–1363

    Article  CAS  Google Scholar 

  16. McGlone T, Briggs NEB, Clark CA, Brown CJ, Sefcik J, Florence AJ (2015) Oscillatory flow reactors (OFRs) for continuous manufacturing and crystallization. Org Process Res Dev 19(9):1186–1202

    Article  CAS  Google Scholar 

  17. Schaber SD, Gerogiorgis DI, Ramachandran R, Evans JMB, Barton PI, Trout BL (2011) Economic analysis of integrated continuous and batch pharmaceutical manufacturing: a case study. Ind Eng Chem Res 50(17):10083–10092

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical and Process Engineering, University of Strathclyde, Glasgow, G1 1QX, UK

    Christopher J. Price

Authors
  1. Christopher J. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher J. Price .

Editor information

Editors and Affiliations

  1. School of Chemical & Process Engineering, University of Leeds, Leeds, United Kingdom

    Kevin J. Roberts

  2. Pfizer Global R&D, Pharmaceutical Sciences, Pfizer Global R&D, Sandwich, Kent, United Kingdom

    Robert Docherty

  3. Graduate School of Human and Environmental Studies, Kyoto University, Sakyo-ku, Kyoto, Japan

    Rui Tamura

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Price, C.J. (2017). Continuous Pharmaceutical Crystallization from Solution. In: Roberts, K., Docherty, R., Tamura, R. (eds) Engineering Crystallography: From Molecule to Crystal to Functional Form. NATO Science for Peace and Security Series A: Chemistry and Biology. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1117-1_19

Download citation

Publish with us

Policies and ethics

Search

Navigation